GlobalData
GlobalData

Press Release

Despite Phase III failure, Gilead’s selonsertib may still have place in NASH combination therapy strategy, says GlobalData

Despite its failure in the Phase III STELLAR-4 trial, Gilead Sciences’ lead non-alcoholic steatohepatitis (NASH) drug candidate, selonsertib, may still have a place in NASH combination therapy strategy, according to GlobalData, a leading data and analytics company. On 11 February 2019, the American biotechnology giant announced that selonsertib did not meet its primary endpoint in […]
Read more

AI in epidemiology could lead to more efficient identification of the source of foodborne illness, says GlobalData

Following the news that researchers at the University of Georgia developed an Artificial Intelligence (AI) process that can help identify the source of a Salmonella outbreak, Ana Fernandez Menjivar, Senior Epidemiologist at GlobalData, a leading data and analytics company, offers her view on the impact of this innovation: “As more machines are able to comb […]
Read more

China and Nigeria will spearhead global planned refining industry capex and capacity additions to 2023, says GlobalData

China and Nigeria are expected to be the major contributors to the global refining industry capacity growth from planned and announced projects between 2019 and 2023, according to GlobalData, a leading data and analytics company. The company’s report: ‘Global Planned Refining Industry Outlook to 2023 – Capacity and Capital Expenditure Forecasts with Details of All […]
Read more

Stem cell therapy offers potential for thalassemia patients to have fewer blood transfusions, says GlobalData

The possibility of using hematopoietic stem cells to restore production of normal hemoglobin is being investigated as a potential strategy to reduce the number of blood transfusions for thalassemia patients. Magdalene Crabbe, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “In clinical trials, stem cells from the bone marrow of […]
Read more

UCB’s partnership with Epilepsy Society offers strategic advantage to further their position in epilepsy, says GlobalData

UCB’s £2.5 million genomic research program with Epilepsy Society has the potential to transform the diagnosis and treatment of epilepsy patients, says GlobalData, a leading data and analytics company. The program is expected to be pioneering for a number of reasons. Most important of which is the rich source of clinical data available from the […]
Read more

Cloud-based reactive microservices support engaging user experiences, says GlobalData

One of the year’s most significant DevOps innovations will be the release of reactive microservices through new cloud platform services, enabling real-time streaming and AI capabilities to support the industry’s most engaging user experiences (UX). Charlotte Dunlap, Principal Analyst at GlobalData, a leading data and analytics company, offers her insight on why reactive microservices are […]
Read more

Brewers adopting AI must be wary of challenges, says GlobalData

After disrupting different industries, artificial intelligence (AI) now finds its way through the beverage industry. Against this backdrop, Shagun Sachdeva, Consumer Insights Analyst at GlobalData, offers her view on the impact of AI in the brewery industry: “Technologies such as AI and machine learning are shaping a new era of personalization, giving rise to new […]
Read more
1 34 35 36 37 38 61